All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

3,685

Reset

3,685 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • LY3884963Phase 21 trial

    Prevail Therapeutics · Frontotemporal Dementia

  • LY3938577Phase 21 trial

    Eli Lilly · Diabetes Mellitus, Type 2

  • LY3972406Phase 21 trial

    Eli Lilly · Plaque Psoriasis

  • LY4086940Phase 21 trial

    Eli Lilly · Obesity, Overweight

  • LY4100511Phase 21 trial

    DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company · Plaque Psoriasis

  • LY4515100Phase 21 trial

    Eli Lilly · Acute Pain, Molar, Molar, Third

  • LYL273Phase 21 trial

    Lyell Immunopharma, Inc. · Colorectal Cancer

  • LYS006Phase 21 trial

    Novartis · Hidradenitis Suppurativa

  • LYT-200Phase 21 trial

    PureTech · Metastatic Cancer, Solid Tumor, Head and Neck Cancer

  • M5717Phase 21 trial

    Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany · Malaria Infection

  • M6223Phase 21 trial

    EMD Serono Research & Development Institute, Inc. · Locally Advanced or Metastatic Urothelial Carcinoma

  • MAR002Phase 21 trial

    Marea Therapeutics · Acromegaly

  • MAX-001Phase 21 trial

    Maxona Pharmaceuticals, Inc. · Impacted Third Molar Tooth, Tooth Extraction Status Nos

  • MAX-40279Phase 21 trial

    Maxinovel Pty., Ltd. · Acute Myeloid Leukemia

  • MB-001Phase 21 trial

    Mage Biologics · Ulcerative Colitis (UC)

  • MBF-015Phase 21 trial

    Medibiofarma S.L. · Huntington Disease

  • MBK-01Fecal Microbiota Transplantation, Intestinal Microbiota TransplantationPhase 21 trial

    Mikrobiomik Healthcare Company S.L. · Diverticulitis, Diverticulitis of Sigmoid

  • MBS303Phase 21 trial

    Beijing Mabworks Biotech Co., Ltd. · Non-Hodgkin's Lymphoma

  • MDSY-1240Phase 21 trial

    Medsyn Biopharma, LLC · Triple-Negative Breast Cancer (TNBC), Gastric Cancer (GC), Gastric Cancer Adenocarcinoma Metastatic

  • MDX2001Phase 21 trial

    ModeX Therapeutics, An OPKO Health Company · Biliary Tract Cancer, Breast Cancer, Cervical Cancer

  • MDX2003Phase 21 trial

    ModeX Therapeutics, An OPKO Health Company · Lymphoma, Waldenström Macroglobulinemia (WM), DLBCL - Diffuse Large B Cell Lymphoma

  • MDX2004Phase 21 trial

    ModeX Therapeutics, An OPKO Health Company · Advanced Tumors

  • ME-401Phase 21 trial

    Kyowa Kirin Co., Ltd. · Indolent B-cell Non-Hodgkin's Lymphoma

  • MEDI0618Phase 21 trial

    AbbVie · Migraine

  • MEN1703SEL24, Dapolsertib hydrochloridePhase 21 trial

    Ryvu Therapeutics SA · Non-Hodgkin Lymphoma, B-cell

  • MEN2312Phase 21 trial

    Stemline Therapeutics, Inc. · Hematological Malignancy

  • MerestinibLY2801653Phase 21 trial

    Eli Lilly · Biliary Tract Cancer, Metastatic Cancer, Advanced Cancer

  • MET233Phase 21 trial

    Pfizer · Obesity and Obesity-related Medical Conditions

  • MF-300Phase 21 trial

    Epirium Bio Inc. · Sarcopenia in Elderly

  • MGT-006Phase 21 trial

    Metagen Therapeutics, Inc. · Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate

  • MHB009CPhase 21 trial

    Minghui Pharmaceutical (Hangzhou) Ltd · Advanced Malignant Solid Tumor

  • MHB034CPhase 21 trial

    Minghui Pharmaceutical (Shanghai) LTD · Advanced Malignant Solid Tumor

  • MHB042CPhase 21 trial

    Minghui Pharmaceutical (Hangzhou) Ltd · Advanced Malignant Solid Tumor

  • MHB046CPhase 21 trial

    Minghui Pharmaceutical (Hangzhou) Ltd · Advanced Solid Cancer

  • MHB048CPhase 21 trial

    Minghui Pharmaceutical (Hangzhou) Ltd · mCRPC (Metastatic Castration-resistant Prostate Cancer), Advanced Malignant Solid Tumor

  • MHS-1031Panosyl-isomaltooligosaccharidePhase 21 trial

    Microbiome Health Sciences · Gastroesophageal Reflux

  • MIL116Phase 21 trial

    Beijing Mabworks Biotech Co., Ltd. · Immunoglobulin A Nephropathy

  • MIT-001Phase 21 trial

    MitoImmune Therapeutics · Head and Neck Squamous Cell Carcinoma, Oral Mucositis

  • MIV-818Phase 21 trial

    Medivir · Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma, Liver Metastases

  • MizagliflozinPhase 21 trial

    Vogenx, Inc. · Postbariatric Hypoglycemia

  • MK-1200Phase 21 trial

    Merck & Co. · Advanced Solid Tumors

  • MK-1439APhase 21 trial

    Merck & Co. · Human Immunodeficiency Virus (HIV) Infection

  • MK-2214Phase 21 trial

    Merck & Co. · Early Alzheimer's Disease

  • MK-2750Phase 21 trial

    Merck & Co. · Advanced Solid Tumors, Malignant Neoplasm

  • MK-6916Phase 21 trial

    Merck & Co. · Pain Management

  • MK-8690PRA052Phase 21 trial

    Merck & Co. · Colitis Ulcerative, Ulcerative Colitis

  • MKP10241Phase 21 trial

    Mankind Pharma Limited · Type 2 Diabetes Mellitus (T2DM), Food Effect, Safety and Tolerability

  • ML-016iNPG-pDoxPhase 21 trial

    BrYet US, Inc. · Advanced Solid Tumor With Lung and/or Liver Involvement

  • MLD10Phase 21 trial

    Pharmalyte Solutions LLC · Hypomagnesemia in Type 2 Diabetic Patients

  • MN-001Phase 21 trial

    MediciNova · Diabetes Mellitus, Type 2, Hypertriglyceridemia, Non-Alcoholic Fatty Liver Disease

NewerPage 61 of 74Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.